BioAbsorb is a next-generation metabolic research complex that combines low-dose metformin, highly bioavailable dihydroberberine, and activated B-complex cofactors. This synergistic blend is designed to amplify glucose disposal, improve lipid and vascular health, enhance mitochondrial energy production, and maintain methylation balance.
Mechanistic Claims
- Metformin (125 mg)
- Activates AMPK, improving insulin sensitivity and glucose uptake.
- Enhances GLUT-4 translocation for efficient glucose disposal.
- Provides metabolic benefits in models of insulin resistance.
- DihydroBerberine (125 mg)
- Highly absorbable berberine metabolite with superior bioavailability.
- Improves glycemia and lipid profiles.
- Supports cardiometabolic health via dual AMPK activation.
- Vitamin B₁ (Thiamin, 12.5 mg)
- Cofactor for pyruvate dehydrogenase.
- Restores endothelial function and supports vascular health.
- Vitamin B₂ (Riboflavin, 12.5 mg)
- Precursor to FAD.
- Shown to lower blood pressure in MTHFR-677TT carriers.
- Vitamin B₅ (Pantethine, 12.5 mg)
- Precursor to CoA.
- Reduces LDL-C and non-HDL-C levels.
- Vitamin B₆ (Pyridoxal-5-Phosphate, 17.5 mg)
- Active PLP coenzyme.
- Decreases plasma homocysteine concentrations.
- Vitamin B₉ (Methyl-folate, 200 mcg)
- Active folate form.
- Supports one-carbon metabolism and homocysteine control.
- Vitamin B₁₂ (Methyl-cobalamin, 50 mcg)
-
- Active B₁₂ form.
- Neuroprotective; improves nerve conduction and methylation balance.
Research Areas
- Glucose Disposal & Insulin Sensitivity: Dual AMPK activation via metformin and dihydroberberine.
- Lipid & Cardiovascular Support: Pantethine and riboflavin improve lipid profiles and vascular function.
- Mitochondrial Energy Metabolism: B-complex cofactors enhance ATP production and enzymatic efficiency.
- Methylation & Homocysteine Management: Methyl-folate and methyl-cobalamin maintain one-carbon balance.
- Neuroprotection & Peripheral Nerve Health: Active B₁₂ supports nerve conduction and resilience.
Research Insights
Glucose Disposal & Insulin Sensitivity
Metformin activates hepatic and skeletal-muscle AMPK, suppressing gluconeogenesis and potentiating insulin-stimulated glucose uptake [1] . Dihydroberberine, a reduced berberine metabolite with far superior intestinal absorption, demonstrated greater area-under-the-curve exposure and produced acute reductions in post-prandial glucose in a randomized crossover pilot trial [2] .
Lipid & Endothelial Support
Pantethine (vitamin B₅ derivative) lowered total and LDL cholesterol by 11 % over 16 weeks in a triple-blinded, diet-controlled trial [5] . Low-dose thiamine reversed hyperglycemia-induced endothelial cell dysfunction in vitro, restoring migration capacity and reducing von Willebrand factor secretion [3] . Riboflavin supplementation (1.6 mg day⁻¹) produced clinically meaningful blood-pressure reductions in treated hypertensives carrying the MTHFR 677TT polymorphism [4] .
Methylation & Homocysteine Management
In a randomized controlled trial, combined methyl-folate (5-MTHF), PLP and methyl-cobalamin lowered plasma homocysteine by 30 % and LDL-C by 7.5 % after six months in adults with MTHFR/MTR/MTRR polymorphisms [7] . Independent PLP supplementation has likewise been shown to cut homocysteine while enhancing antioxidant capacity in postsurgical patients [6] .
Neuroprotection & Nerve Health
A 2020 systematic review and meta-analysis of randomized trials found that mecobalamin (methyl-B₁₂) significantly improved nerve-conduction velocity and overall clinical response in peripheral neuropathy, with a favorable safety profile [8] .
References
- Zhou G et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167-1174. https://pubmed.ncbi.nlm.nih.gov/11602624/
- Moon JM et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia. Nutrients. 2022;14(1):124. https://pubmed.ncbi.nlm.nih.gov/35010998/
- Ascher E et al. Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells. Surgery. 2001;130:851-858. https://pubmed.ncbi.nlm.nih.gov/11685195/
- Wilson CP et al. Blood pressure in hypertensive individuals with the MTHFR 677TT genotype is responsive to riboflavin: targeted randomized trial. Hypertension. 2013;61:1302-1308. https://pubmed.ncbi.nlm.nih.gov/23608654/
- Evans M et al. Pantethine favorably alters LDL and non-HDL cholesterol in low-to-moderate risk subjects. Vasc Health Risk Manag. 2014;10:89-100. https://pubmed.ncbi.nlm.nih.gov/24600231/
- Cheng SB et al. Vitamin B-6 supplementation reduces plasma homocysteine in hepatocellular-carcinoma patients after resection. Biomed Res Int. 2016;2016:7658981. https://pubmed.ncbi.nlm.nih.gov/27051670/
- Pokushalov E et al. Methylfolate, PLP and methylcobalamin supplementation lowers homocysteine and LDL-C: randomized controlled trial. Nutrients. 2024;16:1550. https://pubmed.ncbi.nlm.nih.gov/38892484/
- Sawangjit R et al. Efficacy and safety of mecobalamin on peripheral neuropathy: systematic review and meta-analysis. J Altern Complement Med. 2020;26:1117-1129. https://pubmed.ncbi.nlm.nih.gov/32716261/
| Supplement Facts Serving Size: 1 Capsule Servings per Container: 60 |
|
| Ingredients | Amount Per Serving |
| Metformin | 125 mg |
| DihydroBerberine | 125 mg |
| Vitamin B₁ (Thiamin) | 12.5 mg |
| Vitamin B₂ (Riboflavin) | 12.5 mg |
| Vitamin B₅ (Pantethine) | 12.5 mg |
| Vitamin B₆ (Pyridoxal-5-Phosphate) | 17.5 mg |
| Vitamin B₉ (Methyl-folate) | 200 mcg |
| Vitamin B₁₂ (Methyl-cobalamin) | 50 mcg |